WallStreetZenWallStreetZen

NASDAQ: LUCD
Lucid Diagnostics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for LUCD

Based on 3 analysts offering 12 month price targets for Lucid Diagnostics Inc

Min Forecast
$2.00+101.21%
Avg Forecast
$4.25+327.57%
Max Forecast
$7.75+679.68%

Should I buy or sell LUCD stock?

Based on 3 analysts offering ratings for Lucid Diagnostics Inc.

Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although LUCD's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates LUCD as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their LUCD stock forecasts and price targets.

LUCD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-13
lockedlocked$00.00+00.00%2025-06-06
lockedlocked$00.00+00.00%2025-05-15

1 of 1

Forecast return on equity

Is LUCD forecast to generate an efficient return?

Company
-496.72%
Industry
18.73%
Market
-18.47%
LUCD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LUCD forecast to generate an efficient return on assets?

Company
-100.99%
Industry
10.36%
LUCD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LUCD earnings per share forecast

What is LUCD's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.45
Avg 2 year Forecast
-$0.36

LUCD revenue forecast

What is LUCD's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$5.0M+14.68%
Avg 2 year Forecast
$10.0M+129.36%
LUCD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LUCD revenue growth forecast

How is LUCD forecast to perform vs Medical Devices companies and vs the US market?

Company
14.68%
Industry
5.48%
Market
119.14%
LUCD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LUCD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LUCD vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
LUCD$0.99$4.25+327.57%Strong Buy
RPID$2.46$8.00+225.20%Strong Buy
NSPR$2.41$4.00+65.98%Strong Buy
HYPR$1.27$1.28+1.02%Strong Buy
QIPT$2.17$3.15+45.16%Buy
View Top Medical Device Stocks

Lucid Diagnostics Stock Forecast FAQ

Is Lucid Diagnostics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: LUCD) stock is to Strong Buy LUCD stock.

Out of 3 analysts, 1 (33.33%) are recommending LUCD as a Strong Buy, 2 (66.67%) are recommending LUCD as a Buy, 0 (0%) are recommending LUCD as a Hold, 0 (0%) are recommending LUCD as a Sell, and 0 (0%) are recommending LUCD as a Strong Sell.

If you're new to stock investing, here's how to buy Lucid Diagnostics stock.

What is LUCD's earnings growth forecast for 2025-2026?

(NASDAQ: LUCD) Lucid Diagnostics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 28.49%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 55.22%.

Lucid Diagnostics's earnings in 2025 is -$67,818,000.On average, 1 Wall Street analyst forecast LUCD's earnings for 2025 to be -$48,814,873, with the lowest LUCD earnings forecast at -$48,814,873, and the highest LUCD earnings forecast at -$48,814,873.

In 2026, LUCD is forecast to generate -$39,051,898 in earnings, with the lowest earnings forecast at -$39,051,898 and the highest earnings forecast at -$39,051,898.

What is LUCD's revenue growth forecast for 2025-2026?

(NASDAQ: LUCD) Lucid Diagnostics's forecast annual revenue growth rate of 14.68% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 5.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 119.14%.

Lucid Diagnostics's revenue in 2025 is $4,360,000.On average, 1 Wall Street analysts forecast LUCD's revenue for 2025 to be $542,387,475, with the lowest LUCD revenue forecast at $542,387,475, and the highest LUCD revenue forecast at $542,387,475.

In 2026, LUCD is forecast to generate $1,084,774,950 in revenue, with the lowest revenue forecast at $1,084,774,950 and the highest revenue forecast at $1,084,774,950.

What is LUCD's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: LUCD) forecast ROA is -100.99%, which is lower than the forecast US Medical Devices industry average of 10.36%.

What is LUCD's Price Target?

According to 3 Wall Street analysts that have issued a 1 year LUCD price target, the average LUCD price target is $4.25, with the highest LUCD stock price forecast at $7.75 and the lowest LUCD stock price forecast at $2.00.

On average, Wall Street analysts predict that Lucid Diagnostics's share price could reach $4.25 by Aug 13, 2026. The average Lucid Diagnostics stock price prediction forecasts a potential upside of 327.57% from the current LUCD share price of $0.99.

What is LUCD's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: LUCD) Lucid Diagnostics's current Earnings Per Share (EPS) is -$1.03. On average, analysts forecast that LUCD's EPS will be -$0.45 for 2025, with the lowest EPS forecast at -$0.45, and the highest EPS forecast at -$0.45. In 2026, LUCD's EPS is forecast to hit -$0.36 (min: -$0.36, max: -$0.36).

What is LUCD's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: LUCD) forecast ROE is -496.72%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.